APA (7th ed.) Citation

M, G., I, P., DA, H., M, A., M, S., & P, M. (2021). Persistent inhibitor in acquired haemophilia A: A case for emicizumab? Haemophilia : the official journal of the World Federation of Hemophilia, 27(4), e502. https://doi.org/10.1111/hae.14225

Chicago Style (17th ed.) Citation

M, Ganslmeier, Pekrul I, Heinrich DA, Angstwurm M, Spannagl M, and Möhnle P. "Persistent Inhibitor in Acquired Haemophilia A: A Case for Emicizumab?" Haemophilia : The Official Journal of the World Federation of Hemophilia 27, no. 4 (2021): e502. https://doi.org/10.1111/hae.14225.

MLA (9th ed.) Citation

M, Ganslmeier, et al. "Persistent Inhibitor in Acquired Haemophilia A: A Case for Emicizumab?" Haemophilia : The Official Journal of the World Federation of Hemophilia, vol. 27, no. 4, 2021, p. e502, https://doi.org/10.1111/hae.14225.